DUSSELDORF, Germany, July 14, 2010 /PRNewswire-FirstCall/ -- - Group Revenues in the Second Quarter up by 6.8% (Excluding Technical Plastic Systems) - Further Solid Growth of the Pharma Business - Improvement in the Cosmetics and Life Science Research Segments - Operating (Adjusted EBITDA) Margin at High Level of 20.9% - Profit From Operations More Than Doubled to EUR 24.8m - Revenue Guidance for 2010 Specified and Margin Guidance Raised
Gerresheimer AG, one of the leading worldwide suppliers to the pharma and healthcare industry, remained on its growth path during the second quarter of the financial year 2010. "Our business developed very well in the second quarter. The demand for our products in the pharma industry has grown and there has also been an improvement recently in the Cosmetics and Life Science Research businesses," says Uwe Rohrhoff, the new CEO of Gerresheimer AG since June 22, 2010.
In the period from March to May 2010, the company increased its revenues (excluding the Technical Plastic Systems business which has been sold) by 6.8% compared with the prior year. At constant exchange rates the growth rate in the second quarter was 5.6%. During the first six months of the financial year 2010, the revenue growth at constant exchange rates was 3.6%. Revenues in the second quarter totaled EUR 268.8m (second quarter of 2009 excl. Technical Plastic Systems: EUR 251.6m). In addition to sales growth in the segment of primary pharmaceutical packaging, Gerresheimer profited from the improvement in the more cyclical Cosmetics and Life Science Research businesses in the second quarter.
The operating margin (Adjusted EBI
|SOURCE Gerresheimer AG|
Copyright©2010 PR Newswire.
All rights reserved